Skip to main content
Clinical Trials/TCTR20170529001
TCTR20170529001
Completed
Phase 4

Efficacy of once daily versus divided daily administration of low daily dosage (15 mg/day) of methimazole in the induction of euthyroidism in Graves’ hyperthyroidism: A randomized controlled study

one0 sites55 target enrollmentMay 29, 2017

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Graves’ hyperthyroidism
Sponsor
one
Enrollment
55
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
May 29, 2017
End Date
March 1, 2017
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Sponsor
one

Eligibility Criteria

Inclusion Criteria

  • Graves' hyperthyroidism was based on clinical and biochemical features including presence of signs and symptoms of thyrotoxicosis, diffuse enlargement of thyroid gland, and elevated serum free thyroid hormones accompanied with suppressed serum thyroid\-stimulating hormone (TSH) levels.

Exclusion Criteria

  • Other causes of thyrotoxicosis

Outcomes

Primary Outcomes

Not specified

Similar Trials